Indian Journal of Health Sciences and Biomedical Research KLEU (Jan 2019)

Prescribing patterns of Virechana Karma in terms of Shuddhi Lakshana

  • Shawan Barik,
  • Buduru Sreenivasa Prasad

DOI
https://doi.org/10.4103/kleuhsj.kleuhsj_69_18
Journal volume & issue
Vol. 12, no. 2
pp. 139 – 153

Abstract

Read online

BACKGROUND: The widespread use of various drugs in a single procedure and the increasing recognition of Shuddhi achieved as per the classics to provide the best result have stimulated interest in the manner in which physicians prescribe drugs. The main sources of this information can be found at the institutional-level like hospitals. These sources reveal a varied prescribing patterns in terms of drugs used for Snehapana, drugs used for Sarvanga abhyanga, and also in terms of drug selection for Virechana karma. It also reveals the pattern in the selection of dose and the duration of the treatment vary greatly among physicians according to their place, practice, disease, and the condition of the patient. METHODS: Therefore, a prospective study was conducted from May 2016 to December 2017 at KAHER's Shri BMK Ayurveda Hospital and Research Centre, Belagavi, Karnataka, India. A total of 1138 individuals were screened among which 319 individuals were taken as per the inclusion criteria, in which 300 participants completed the study. RESULTS: The outcome was measured on the basis of SamyakShuddhi Lakshana (SSL) of Snehana and Virechana karma. The study revealed that 51.33% of the individuals achieved avaraShuddhi, 42.33% achieved MadhyamaShuddhi, and 6.34% achieved PravaraShuddhi. In mridu koshtha, a total of 160–200 ml of ghrita intake can attain 10–11 vegas, in Madhyama koshtha total of 295–1130 ml of ghrita intake can attain 13–18 vegas, and in krurukoshtha total of 90–520 ml of ghrita intake can attain up to 21 vegas over a period of 3 or 5 days. 92.67% times Trivritleha was observed as prescribed drug which also has 30 min onset of Virechanavega with proper snehaSamyakShuddhi. DISCUSSION AND CONCLUSION: The study is the precursor to improve prescribing patterns and quality of care and thus provides a population based approach to advance clinical pharmacology and improved health outcomes resulting from improved prescribing choices.

Keywords